NJ Bio
Princeton
About NJ Bio
NJ Bio, Inc. is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in integrated chemistry and biology services for the biotech and pharmaceutical industries. The company offers a wide range of services, including antibody-drug conjugates, protein production, cell-based assays, and bioanalytical services, all aimed at accelerating product development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $15.6M
- Funding stage: M&A
- Last round: Corporate Round (Aug 2025)
- Website: njbio.com
- Phone: 732-202-5664
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nj-bio-7775 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.